Intuitive Surgical stock faces downward pressure due to Johnson & Johnson securing FDA marketing authorization
Statements (16)
- Bearish
Intuitive Surgical stock has dropped 29% this year.
- Bearish
Intuitive Surgical has lagged broader equities this year
- Bullish
Intuitive Surgical (ISRG) is likely to see its stock price rise following the analyst upgrade from Perform to Outperform, driven by expectations of growth in robotic surgery.
- Bullish
Oppenheimer set a $500 price target for Intuitive Surgical
- Bearish
Intuitive Surgical stock has plunged 33% in 2026.
- Bearish
Intuitive Surgical (NASDAQ: ISRG) shares could face significant pressure following its reported stock plunge of 33% in 2026.
- Bearish
Intuitive Surgical stock is down 30.54% year to date
- Bearish
Intuitive Surgical stock is down roughly 40% from its early 2025 high
- Bearish
Intuitive Surgical's stock price could continue to decline as competition intensifies in the MedTech sector.
- Bullish
Intuitive Surgical trades at $373.71 with an average Wall Street price target of $477.25
- Bearish
Intuitive Surgical is likely to see its stock price decline as Wall Street Bull pegs returns at 85%.
- Bearish
Intuitive Surgical stock may face increased pressure as analysts cut targets following UBS's warning about the company's solvency concerns.
- Bearish
Intuitive Surgical stock has been punished by market, down about 37% despite revenue climbing.
- Bullish
Intuitive Surgical is likely to see its stock price rise significantly as Wall Street analysts project a substantial upside to its valuation.
- Bullish
Intuitive Surgical is likely to see its stock price rise following its upgrade to Buy from Neutral by UBS.
- Bullish
UBS upgraded Intuitive Surgical to Buy from Neutral with a price target of $500